Ship of Theseus, LLC
Publicly observedEagleville, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Eagleville | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Ship of Theseus, LLC | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | NBZMY6CX12K6 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant10 Sept 2025Publicly observed
NIH SBIR/STTR award: Preclinical development of a tandem CART / HSC transplantation platform for hematologic malignancies
USD 399,739.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant10 Aug 2021Publicly observed
NIH SBIR/STTR award: Stimulant for stem cell expansion in vivo to speed recovery of neutropenia secondary to chemotherapy and stem cell transplant
USD 50,000.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant10 Aug 2021Publicly observed
NIH SBIR/STTR award: Stimulant for stem cell expansion in vivo to speed recovery of neutropenia secondary to chemotherapy and stem cell transplant
USD 324,853.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
- Grant10 Aug 2021Publicly observed
NIH SBIR/STTR award: Stimulant for stem cell expansion in vivo to speed recovery of neutropenia secondary to chemotherapy and stem cell transplant
USD 1,770,171.00 · National Heart Lung and Blood Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.